Hostname: page-component-cd9895bd7-mkpzs Total loading time: 0 Render date: 2024-12-26T21:11:31.177Z Has data issue: false hasContentIssue false
  • English
  • Français

Management of neuroendocrine small cell carcinoma of cervix-a single centre retrospective study

Published online by Cambridge University Press:  02 April 2012

Ursula Mcgivern ,
Jacqueline Clarke ,
Anne Drake ,
Glenn McGluggage  and
Jonathan McAleese
Ursula Mcgivern*
Affiliation:
Belfast City Hospital, Belfast, United Kingdom
Jacqueline Clarke
Affiliation:
Belfast City Hospital, Belfast, United Kingdom
Anne Drake
Affiliation:
Belfast City Hospital, Belfast, United Kingdom
Glenn McGluggage
Affiliation:
Belfast City Hospital, Belfast, United Kingdom
Jonathan McAleese
Affiliation:
Belfast City Hospital, Belfast, United Kingdom
*
Correspondence to: Ursula Mcgivern, Belfast City Hospital, Belfast, United Kingdom. E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Purpose: To determine disease-free and overall survival of neuroendocrine small cell cancer of cervix treated at the Northern Ireland Cancer centre between 1999 and 2010.

Materials and methods: A retrospective review of all patients diagnosed and treated with neuroendocrine small cell cancer of cervix in Northern Ireland. Details of treatment modality including chemotherapy, radiotherapy and surgery were recorded.

Results: Fifteen patients diagnosed with neuroendocrine small cell carcinoma (NSCC) of cervix were identified between 1999 and 2010, twelve with disease localised to the pelvis and three with metastatic disease. Three-year overall survival for all patients was 65% and disease-free survival was 45% for all patients. In patients with pelvic confined disease 3-year overall survival was 79% and disease-free survival was 57%. Median disease-free and overall survival was 30 and 39.6 months respectively. These survival rates compare very favourably to those reported in the literature. Stage of disease at diagnosis was the main determinant of survival.

Conclusion: Local control and survival can be achieved in NSCC of patients with a combination of irradiation and platinum-based chemotherapy. Stage of disease determines outcomes.

Keywords

Cervical carcinomaNeuroendocrine small cell carcinomaRadiotherapy
Type
Original Article
Information
Journal of Radiotherapy in Practice , Volume 12 , Issue 2 , June 2013 , pp. 146 - 153
Copyright
Copyright © Cambridge University Press 2012

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Duguid, J, Kennedy, A. Oat cell tumours in mediastinal glands. J Pathol Bacteriol 1930; 33:93–99.CrossRefGoogle Scholar
Albores-Saavedra, J, Larraza, O, Poucell, S, Rodriguez Martinez, H. Carcinoid of the uterine cervix: additional observations on a new tumour entity. Cancer 1976; 38:2328–2342.3.0.CO;2-J>CrossRefGoogle Scholar
McCluggage, WG, Kennedy, K, Busam, K. An Immunohistochemical Study of Cervical Neuroendocrine Carcinomas: Neoplasms That are Commonly TTF1 Positive and Which May Express CK20 and P63. American Journal of Surgical Pathology 2010; 34:525–532.CrossRefGoogle ScholarPubMed
Van Nagell, JR, Powell, DE, Gallion, HH, et al. : Small cell carcinoma of the uterine cervix. Cancer 1988; 62:1586–1593.3.0.CO;2-W>CrossRefGoogle ScholarPubMed
Cohen, JG, Kapp, DS, Shin, JY, et al. . Small cell carcinoma of the cervix: treatment and survival outcomes of 188 patients. Am J Obstet Gynecol 2010; 203:347.e1–e6.CrossRefGoogle ScholarPubMed
Hoskins, PJ, Swenerton, KD, Pike, JA, Lim, P, Aquino-Parsons, A, Wong, F, and Lee, N. Small-Cell Carcinoma of the Cervix: Fourteen Years of experience at a single institution using a combined-modality regimen of involved-field irradiation and platinum-based combination chemotherapy. Journal of Clinical Oncology: 2003 Vol 21, No 18 (September 15): pp 3495–3501Google Scholar
Kim, JH, Lee, S, Park, J, et al. . Extrapulmonary small-cell carcinoma: a single-institution experience. Jpn J Clin Oncol. 2004; 34: 250–254CrossRefGoogle ScholarPubMed
Zivanovic, M.M., Leitao, K.J. Jr., Park, H., Zhao, J.P., Diaz, et al. Small cell neuroendocrine carcinoma of the cervix: Analysis of outcome, recurrence pattern and the impact of platinum-based combination chemotherapy. Gynecologic Oncology 2009; 112 590–593CrossRefGoogle ScholarPubMed
Auperin, A, Arriagada, R, Pignon, JP, et al. . Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic cranial irradiation overview collaborative group. N Engl J Med 1999; 341:476–84Google Scholar
Cicin, I, Karagol, H, Uzunoglu, S, et al. . Extrapulmonary small-cell carcinoma compared with small-cell lung carcinoma: a retrospective single-center study. Cancer 2007; 110:1068–1076.CrossRefGoogle ScholarPubMed
Weed, JC Jr, Graff, AT, Shoup, B, Tawfik, O. Small cell undifferentiated (neuroendocrine) carcinoma of the uterine cervix. J Am Coll Surg 2003; 197:44–51.Google Scholar
Sheets, EE, Berman, ML, Hrountas, CK, et al. : Surgically treated, early-stage neuroendocrine small-cell cervical carcinoma. Obstet Gynecol 1998; 71:10–14.Google Scholar
Sevin, B-U, Method, MW, Nadji, M, et al. : Efficacy of radical hysterectomy as treatment for patients with small cell carcinoma of the cervix. Cancer 1996; 77:1489–1493.Google Scholar
Walker, AN, Mills, SE, Taylor, PT: Cervical neuroendocrine carcinoma: A clinical and light microscopic study of 14 cases. Int J Gynecol Pathol 1998; 7:64–74.CrossRefGoogle Scholar
Gersell, DJ, Mazoujian, G, Mutch, DG, et al. : Small cell undifferentiated carcinoma of the cervix: A clinicopathologic, ultrastructural and immunocytochemical study of 15 cases. Am J Surg Pathol 1998; 12:684–698.Google Scholar
Miller, B, Dockter, M, El Torky, M, et al. : Small cell carcinoma of the cervix: A clinical and flow cytometric study. Gynecol Oncol 1991: 42:27–33.Google Scholar
Abeler, VM, Holm, R, Nesland, JM, et al. : Small cell carcinoma of the cervix: A clinicopathologic study of 26 patients. Cancer 1973; 672–677Google Scholar
Sykes, AJ, Shanks, JH, Davidson, SE: Small cell carcinoma of the uterine cervix: A clinicopathological review. Int J Oncol 1999; 14:381–386Google Scholar
Morris, M, Gershenson, DM, Eifel, P, et al. : Treatment of small cell carcinoma of the cervix with cisplatin, doxorubicin and etoposide. Gynecol Oncol 1992; 47:62–65.CrossRefGoogle ScholarPubMed
Delaloge, S, Pautier, P, Kerbrat, P, Castaigne, D, Haie-Meder, C, Duvillard, P, Guivarch, C, Goupil, A, Borel, C, Lhommé, C. Neuroendocrine small cell carcinoma of the uterine cervix: what disease? what treatment? Report of ten cases and a review of the literature. Clinical Oncology 2000; 12:6 357–363.Google Scholar
Akila N., Viswanathan, Michael T., Deavers, Anuja, Jhingran, Pedro T., Ramirez, Charles, Levenback, Patricia, J. Eifel Small cell neuroendocrine carcinoma of the cervix:outcome and patterns of recurrence. Gynecologic Oncology 2004; 27–33.Google Scholar
Lee, JM, Lee, KB, Nam, JH, et al. . Prognostic factors in FIGO stage IB-IIA small cell neuroendocrine carcinoma of the uterine cervix treated surgically: results of a multi-center retrospective Korean study. Ann Oncol 2008; 19:321–326.CrossRefGoogle ScholarPubMed